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HIS
report has a threefold purpose:
(1) to describe a simple, clinical method of estimating myocardial threshold in patients with artificial pacemakers, (2) to verify the importance of critically high threshold as a significant cause of "pacemaker failure," and (3) to suggest for this type of failure a nonsurgical method of restoring myocardial responsiveness by administration of glucocorticoid and sympathomimetic drugs.
Although threshold problems have been previously reported in conjunction with at least three commercially available implantable pacemakers,lM3 the biologic consequences of prolonged artificial pacing have not been systematically investigated to date. Several reports have emphasized the technologic causes for pacemaker failure,4-7 and considerable effort has been expended toward the development of improved leads, better pulse generators and longer battery life. These latter considerations are fundamentally engineering problems to which the physician directly contributes very little, except as he serves as an evaluator and advisor.
In calling particular attention to the biologic basis for pacemaker failure, referred to subsequently as exit block, we would like to emphasize the need for (1) ways of serially evaluating pacemaker function following implantation and (2) precise diagnosis of the cause of failure when it occurs unexpectedly.
We feel the method here described holds great promise as means of meeting both of these needs.
MATERIALS AND METHODS
In developing a means of quantitating the myocardial threshold level, we took advantage of the features incorporated into the design of our pacemaker (General Electric Co.), which allowed variation in the rate by an externally applied, inductioncoupled, control unit.
By a similar method shown in Figure 1 , a threshold analyzer has been constructed which prevents the discharge of the output condenser of the implanted unit by introducing a high frequency (2,000 c.p.s.), low energy (1.45 microjoules) signal. The amplitude of each subsequent pacemaker stimulus is then inversely proportional to the number of suppression pulses introduced. By this means the rate of the implanted pacemaker can then be varied from 60 to 120 pulses per minute and the output energy per pulse can be suppressed to 2.5 per cent of normal.
The technical details of this instrument will be reported elsewhere and are beyond the scope of this presentation.
Operation of the threshold analyzer can be performed by one physician.
The electrocardiogram is observed continuously on a separate cardiac monitor. The first step is to place the induction coil directly over the implanted pacemaker. When sufficient inductive coupling is present, as registered by a simple galvanometer incorporated into the instrument, the analyzer is turned on and allowed to capture control of the rate of the implanted unit.
The rate is then adjusted as desired, and the output signal of the implanted pacemaker is displayed on a Tektronix 502A oscilloscope with a 10 msec., synchronized sweep. This allows continuous monitoring of exact rate and pulse width. 8 A simple electronic counter can also be used to display these two parameters.
Finally, through one control dial, the energy delivered by the implanted unit can be slowly reduced.
Threshold is 'l'hrcshold energy \vah calculated from direct voltage and current measurements. Threshold was then determined by reducing the pacemaker energy supplied to the myocardial Aectrodes by means of resistances placed in series and in parallel with the myocardial electrodes. 'l'hreshold energy by the second method was also calculated by direct voltage and current measurements, and found to be exactly the same as that determined by the threshold analyzer, therefore demonstrating that the threshold analyzer itself does not alter threshold.
The threshold analyzer wasjrst applied to a patient &lose myocardial electrodes zuere e.\posed for direct measurements. Threshold energy was determined by the pulse width method described above, and simultaneously by measurements of direct current and voltage from the exposed electrodes.
Calculation of threshold energy by these two methods varied by 1 per cent, which is within the limit of error for the pulse width method.
A total of 774 threshold measurements were then made externally on a series of W patients, by using the threshold analyzer as already described.
In each case, threshold energy was calculated as per cent of total energy available. Figure 2 sho\ys gradual reduction of pacemaker energy until the pulse energy is below that required for stimulation and asystolc results. For purposes of standardization, wr have defined threshold as that energy level at or below which at least one out of every ten pacemaker pulses fails 10 cffcct myocardial stimulation.
For practical rcaqons, we attain threshold by slowly reducing pacemaker energy until one or more stimuli out of every tc'n fails to excite the heart.
Threshold in all cases is rcportcd as a per cent of available pacemaker cnvrgy.
Ei,ghteen clinical case.) oj exit blot/; rt'ere ident$ed jrom 128 imblantations oL)er a four year /vriod.
The criteria used for exit block were (1) rapidly increasing interelectrode impendanct: and threshold, (2) measurement of pulse width and rate to show that the pacemaker is functioning normally, and C,?) clectrocardiographic demonstration of pacemaker stimuli without concurrent QRS complexes. 'The method of diagnosis of exit block by rate and pulse lviclth analysis has already been reported in detail.% Six surgically removed pacemakers wrre subjected to extensive technical evaluation and were found to be in perfect working order. Three caqcs of exit block have now been diagnosed and followed by accurate threshold measurements.
In the other 15 cases crude measurements of threshold were possible by use of an external rate control, which causes decreased energy output as the rate is increased.9 C, between B and C the output of the implanted unit is slowly decreased, but the heart is still responding. D, the stimulus has been reduced to a subthreshold level, with no myocardial response. The high-frequency artifacts are induced by the threshold analyzer. E, the threshold analyzer is turned off, allowing resumption of normal pacing.
F, return of normal pacing.
Finally, all patients with exit block weregiven drug therapy in an attempt at restoring myocardial responsiveness. A wide variety of drugs and dosage levels were tried, but only two types will be included in this report: glucocorticoids and sympathomimetics.
RESULTS
STUDIES ON DOGS
Studies on dogs showed that during the first week after implantation the threshold is lower than 2.5 per cent of the total pacemaker energy, or less than 1.45 microjoules.
At this low threshold the dogs responded to the high frequency suppression pulses as well as the regular pace pulse, and thus experienced a pacemakerinduced tachycardia with a rate of around 200. This tachycardia is totally dependent on the threshold analyzer and can be terminated immediately by the operator.
It was reproduced 20 times in 6 different dogs, with absolutely no sequellae after termination of the tachycardia by shutting off the threshold analyzer.
In no case did ventricular fibrillation ensue, even when the tachycardia was allowed to persist for relatively long periods (15 to 30 sec.).
In all 6 dogs the threshold level had risen to above 1.45 microjoules by 14 days postimplantation. In no human subject was such an arrhythmia produced, including one measurement taken 2 days following implantation. We do recommend, though, that routine measurements be deferred until the second postoperative week.
Serial measurements on 6 dogs showed that threshold energy increased sharply during the first two weeks and continued to increase up to VOLUME 18, JULY 1966 three months postimplantation. Interelectrode impedance measured externally by methods previously reported showed a concomitant increase.
Direct measurements on 3 of these animals showed that threshold is a function of total energy per pulse, not simply current.
Threshold as measured by this method in dogs and man has a very distinct end-point. Measurements are reproducable by different operators, and accurate to 1 per cent at threshold levels below 50 per cent, and to 2 per cent at levels above 50 per cent.
As threshold with few exceptions remains below 50 per cent, the method is effectively accurate to 1 per cent.
CLINICAL STUDIES
As a clinical tool, the threshold analyzer proved to be simple to operate, practical and safe.
Total threshold analysis takes less than five minutes.
In over 714 determinations on 28 human patients there were no arrhythmias, no significant symptoms during use, and no sequellae.
Most patients reported a light-headed feeling if three or more consecutive heart beats were suppressed.
For this reason, we make it a practice to restore pacing promptly after three stimuli have been missed. This is done by relaxing a control button on top of the coil which is held over the pacemaker, or by lifting the coil away from the pacemaker.
It is necessary at all times that the operator of the threshold analyzer be watching a cardiac monitor so that he can immediately detect any suppressed beats. promises to be a siniple and rational approach to the problem of detecting exit block be/ore failure to pace develops.
It also gives an analytical means of assessing the response to treatment.
Reaction Around Electrodes: Two important factors deserve consideration in exit block: reaction around the electrodes, and responsiveness of the myocardium.
Figures 5 and 6 show perielectrode reaction in two different human patients who died from noncardiac causes. Note that the reaction at 10 days is minimal, whereas the reaction at six months is much greater.
We have previously shown that the interelectrode impedance rises sharply during the first month postimplantation, but usually levels off by three months.
Similarly, evidence to date in dogs and man suggests that the absolute threshold level follows the same pattern, rising during the first three months, after which there is little or no change.
Equating interelectrode impedance and threshold measurements with tissue reaction around the electrodes gives a presumptive method of assessing inter-
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Current or Energy Lines
Mineralocorticoids, on the other ha11t1, apparently increase threshold and, thcrrfore, should he avoided in exit block until their exact cffcct can be clarified by flIrther stlidy. Although prednisone reduces threshold, there is 110 evi----dence as yet that it reduces llltimate perielectrode reaction, and therefore UY do not 11s~ it routinely after implantation.
;\lthough 0111' Ps fibrosis increases around the electrodes, the txergy density at the point of excitation becomes less, thus raising the threshold energy requirement.
electrode tissue changes. Figure 7 is a schelnatic presentation of the perielectrode reaction. Myocardial excitation occurs where the energy density is greatest, and as seen in Figure 7 , fibrosis around the electrodes results in nonresponsive tissue at the areas where the energy density is greatest. ' Thus, the remaining norrnal myocardium between the electrodes is stimulated by a lower energy density, resulting in a higher energy threshold.
&sf,onsiceness of Myocurdium: However, we fotmd no consistent relation between absolute interelectrode impedance values and threshold. Threshold changes secondary to drugs or exercise were not accompanied by significant changes in interelectrode impedance. This observation tended to emphasize the relative importance of a second factor in myocardial electrical stimulation;
i.e., the responsiveness of the myocardium itself. We were unable, however, to demonstrate hypo-or hyperkalemia in any of o11r patients with exit block.
Steroid Therapy for Exit Block:
With the use of the threshold analyzer, the effect of drugs can be measured as definite changes in threshold energy.
Steroid therapy for exit block is now based on clear-cut evidence that glucocorticoids decrease threshold energy requirements. requirements significantly.
Our criterion for treatment to increase m)ocardial responsiveness in impending exit block is now a threshold level which rises above 50 per cent of the pacemaker energy within the first three months. Moreover, if threshold reaches 10 per cent within the first week after implantation, 25 per cent in the first two weeks, or 50 per cent in the first month, exit block is very likely unless prevented by trcatrnent.
In snch cases we recommend treatlllent initially-with 40 mg. of prednisone per day, LInti the threshold either levels off or falls to below 33 per cent (3 : 1 safety factor).
At this point the prednisone should bc reduced to the lowest possible dosage kvhich will sllstain threshold below 33 per cent.
Initially, threshold llleasurements are taken every day.
L4fter stabilization of threshold, measurelncnts arc rcdllced to cvcr\ two to foollr weeks. It is anticipated that by safely reducing pacemaker output energy in such patients, the battery life may be extended significantly, and any potentially harmful effects from excessive current flow between the electrodes also may be minimized.
All the above methods apply to only one pacemaker, but they should be valid whether it is attached to myocardial electrodes or to a transvenous catheter electrode.
The potential value of threshold analysis in pharmacologic research is self-evident.
SUMMARY
A method for estimating myocardial threshold in patients with implanted artificial pacemakers has been described.
By the external application of a calibrated suppression signal, the output of the implanted unit can be gradually reduced until the myocardial response ceases. The threshold level thus determined can be expressed as a per cent of available pulse energy by a simple calculation.
This method promises to have clinical application because it is relatively simple and entirely external.
It has been demonstrated to be safe, no sequelae having occurred during over 700 human studies.
In combination with our previously reported method of estimating interelectrode impedance, it should provide a rational means of serially evaluating pacemaker function following implantation. It is applicable to both direct myocardial and transvenous modes of pacing, but its most important limitation at the present time is that it can be used VOLUME 18, JULY 1966 with only one of the commercially available pacemakers.
BY application
of quantitative threshold measurements, we have been able to confirm our clinical observations of exit block as a significant cause of pacemaker failure.
This complication comprised the second most common cause of failure to pace, 14 per cent in a series of 128 implantations.
It has also been possible by this means to verify the effectiveness of glucocorticoid and sympathomimetic drugs in lowering the myocardial threshold level.
The implications of these observations have been briefly discussed.
Threshold analysis may prove to be an important means of investigating the myocardial effects of other pharmacologic preparations in the future.
